Armata Pharmaceuticals Inc (ARMP)
2.10
+0.01
(+0.48%)
USD |
NYAM |
Nov 21, 16:00
2.10
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Total Assets (Quarterly): 98.24M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 98.24M |
| June 30, 2024 | 108.31M |
| March 31, 2024 | 120.36M |
| December 31, 2023 | 98.36M |
| September 30, 2023 | 112.76M |
| June 30, 2023 | 101.21M |
| March 31, 2023 | 108.78M |
| December 31, 2022 | 95.83M |
| September 30, 2022 | 92.88M |
| June 30, 2022 | 100.98M |
| March 31, 2022 | 107.76M |
| December 31, 2021 | 69.77M |
| September 30, 2021 | 42.67M |
| June 30, 2021 | 48.28M |
| March 31, 2021 | 52.84M |
| December 31, 2020 | 39.52M |
| September 30, 2020 | 45.68M |
| June 30, 2020 | 49.46M |
| March 31, 2020 | 44.10M |
| December 31, 2019 | 25.45M |
| September 30, 2019 | 29.30M |
| June 30, 2019 | 34.92M |
| Date | Value |
|---|---|
| March 31, 2019 | 9.617M |
| December 31, 2018 | 11.89M |
| September 30, 2018 | 10.62M |
| June 30, 2018 | 11.72M |
| March 31, 2018 | 14.40M |
| December 31, 2017 | 11.14M |
| September 30, 2017 | 13.78M |
| June 30, 2017 | 15.11M |
| March 31, 2017 | 14.30M |
| December 31, 2016 | 18.15M |
| September 30, 2016 | 26.04M |
| June 30, 2016 | 29.28M |
| March 31, 2016 | 28.26M |
| December 31, 2015 | 31.49M |
| September 30, 2015 | 34.08M |
| June 30, 2015 | 36.37M |
| March 31, 2015 | 38.60M |
| December 31, 2014 | 28.62M |
| September 30, 2014 | 28.42M |
| June 30, 2014 | 31.26M |
| March 31, 2014 | 34.35M |
| December 31, 2013 | 41.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
25.45M
Minimum
Dec 2019
120.36M
Maximum
Mar 2024
78.16M
Average
94.36M
Median
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.59M |
| Perspective Therapeutics Inc | 391.15M |
| Protalix BioTherapeutics Inc | 61.56M |
| Electromed Inc | 48.92M |
| Xtant Medical Holdings Inc | 98.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 149.21M |
| Shareholders Equity (Quarterly) | -50.97M |